In a historic step forward for gene-based therapy, a comprehensive study led by Dr. Dhani Ram Baruah has been published in Nature Medicine, detailing the remarkable potential of his patented Combat Genes against life-threatening diseases such as cancer, HIV/AIDS, and drug-resistant infections.
What Are Combat Genes?
Combat Genes are a collection of 12 synthetic gene sequences developed using Dr. Baruah’s proprietary siRNA-based platform, extracted and derived from Himalayan medicinal plants. These engineered sequences have shown high efficacy in silencing the expression of disease-driving genes through targeted RNA interference—without harming surrounding healthy tissues.
This innovation stems from over two decades of Dr. Baruah’s research in molecular genetics, xenogenomics, and regenerative biology, carried out at the Dr. Dhani Ram Baruah Heart Institute & Research Centre in Assam, India.
Key Findings from the Study
The published study presents extensive in vitro and in vivo results demonstrating that Combat Genes can:
- Suppress oncogene expression in aggressive cancer cell lines
- Inhibit HIV replication by blocking viral integration pathways
- Trigger immune modulation, enhancing the body’s ability to fight chronic infections
- Target antimicrobial resistance genes, offering a new route to defeating superbugs
The Nature Medicine editorial team called the findings “a breakthrough in translational genetic medicine,” and emphasized the therapeutic versatility of the Combat Genes platform.
International Recognition
This publication marks a major milestone for Indian-led biomedical innovation. Dr. Elena Zhao, lead editor at Nature Medicine, stated:
“Dr. Baruah’s Combat Genes are more than just a scientific achievement—they open a new chapter in how we treat complex, multi-gene-driven diseases using natural molecular intelligence.”
What’s Next?
Following publication, several global research institutes and pharmaceutical companies have expressed interest in collaborating on Phase I human clinical trials. These trials will focus initially on aggressive cancers with limited treatment options, such as pancreatic and triple-negative breast cancer.
Dr. Baruah’s lab is also exploring the integration of Combat Genes with personalized medicine frameworks, using miRNA mapping to tailor gene therapy regimens for individual patients.
A Word from Dr. Baruah
“Nature has always held the answers. It’s our job to decode its language. Combat Genes are a testament to what happens when tradition and technology meet at the cutting edge of medicine.
Add a Comment